<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高季刊</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac&amp;ff=202307 18063150&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U- NVu8003KrCpq8yLQC -<description>心血管高季刊：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac&amp;ff=20230718063150&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 7 月 18 日星期二 10:31:51 +0000</lastbuilddate><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>脊髓损伤个体心血管风险的诊断和管理：叙述性回顾</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459417/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>每年有超过 16 000 名美国人经历脊髓损伤 (SCI)，导致慢性残疾和其他继发后遗症。急性医疗管理的改进提高了预期寿命。心血管疾病是该人群的主要原因，并且似乎与一般人群相比，SCI 患者发生得更早。SCI 患者承受着传统心血管疾病危险因素的沉重负担，包括血脂异常和糖尿病等。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):268-277. doi: 10.1161/CIRCULATIONAHA.123.064859. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">每年有超过 16 000 名美国人经历脊髓损伤 (SCI)，导致慢性残疾和其他继发后遗症。急性医疗管理的改进提高了预期寿命。心血管疾病是该人群的主要原因，并且似乎与一般人群相比，SCI 患者发生得更早。SCI 患者承受着传统心血管疾病危险因素的沉重负担，包括血脂异常和糖尿病，并且表现出解剖、代谢和生理变化，同时受伤后体力活动明显减少。经历与残疾相关的多重、复杂的护理障碍，并且在许多情况下，种族和社会经济健康不平等的交叉影响产生复合效应。考虑到这些危险因素的组合，一些研究人员提出，脊髓损伤患者患心血管疾病的风险增加，超出了其他疾病的风险。与传统风险因素相关的 SCI 可以被视为风险增强因素，类似于 2019 年美国心脏协会/美国心脏病学会一级预防指南定义的其他风险增强因素。人群阐明传统风险因素的作用、新的危险因素、医疗保健的获取、健康的社会决定因素以及残疾、种族和社会经济地位的交叉性。及时诊断和管理 SCI 患者心脏危险因素的重要性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459417/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459417</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064859>10.1161/CIRCULATIONAHA.123.064859</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459417</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>塔拉拉古</dc:creator><dc:creator>萨曼莎·L·施罗斯</dc:creator><dc:creator>卡罗尔·海伍德</dc:creator><dc:creator>艾伦·海涅曼</dc:creator><dc:creator>艾莉森·凯斯勒</dc:creator><dc:creator>莱斯利·莫尔斯</dc:creator><dc:creator>萨迪亚·汗</dc:creator><dc:creator>基亚里·N·克肖</dc:creator><dc:creator>马克·S·纳什</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>脊髓损伤个体心血管风险的诊断和管理：叙述性回顾</dc:title><dc:identifier>下午：37459417</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064859</dc:identifier></item><item><title>促进心源性猝死预防的公平性：谨防对初级预防植入式心脏复律除颤器在黑人患者中的有效性做出假设</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459416/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):253-255. doi: 10.1161/CIRCULATIONAHA.123.065723. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459416/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459416</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065723>10.1161 / CIRCULATIONAHA.123.065723</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459416</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>萨纳·哈提布</dc:creator><dc:creator>——凯文·托马斯</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>促进心源性猝死预防的公平性：谨防对初级预防植入式心脏复律除颤器在黑人患者中的有效性做出假设</dc:title><dc:identifier>下午：37459416</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065723</dc:identifier></item><item><title> 2015 年至 2021 年 ST 段抬高型心肌梗死过程指标和死亡率的种族差异：对美国心脏协会 178 062 名遵循冠状动脉疾病登记指南的患者进行的分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459415/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>结论：女性和男性的 STEMI 过程指标中仍然存在基于种族或民族的差异，与非西班牙裔白人女性相比，西班牙裔白人的死亡率存在差异。进一步的研究对于发展护理系统以减轻种族差异至关重要。 STEMI 结果。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):229-240. doi: 10.1161/CIRCULATIONAHA.123.065512. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：美国各地已开发出护理系统，以标准化护理流程并改善 ST 段抬高型心肌梗死 (STEMI) 患者的预后。STEMI 的治疗目标和死亡率尚不确定。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们分析了 2015 年 1 月 1 日至 2021 年 12 月 31 日期间登记在美国心脏协会指南-冠状动脉疾病登记处的 178 062 名 STEMI 患者（52 293 名女性和 125 769 名男性）。患者被分为比较 3 个种族和民族的结果：非西班牙裔白人、西班牙裔白人和黑人。主要结果是达到以下 STEMI 过程指标的患者比例：通过紧急医疗服务获得的院前心电图；到达医院后 10 天内获得的心电图到达经皮冠状动脉介入治疗的时间在 90 分钟内；首次医疗接触设备的时间在 90 分钟内。次要结果是院内死亡率。对女性和男性分别进行分析，所有结果均根据年龄、合并症、表现的敏锐度、保险状况和社会经济状况，通过基于患者居住县的社会脆弱性指数来衡量。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：与患有 STEMI 的非西班牙裔白人患者相比，西班牙裔白人患者和黑人患者接受院前心电图以及实现上门心电图、上门到设备和首次医疗接触设备目标的几率较低这些治疗目标的种族差异在女性和男性中均观察到，并且在多变量调整后在大多数情况下持续存在。与非西班牙裔白人女性相比，西班牙裔白人女性的调整后院内死亡率更高（比值比，1.39 [95 % CI ，1.12-1.72]），而黑人女性没有（比值比，0.88 [95% CI，0.74-1.03]）。比值比，0.99 [95% CI，0.82-1.18]）和黑人男性（比值比，0.96 [95% CI，0.85-1.09]）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：女性和男性的 STEMI 过程指标中仍然存在基于种族或民族的差异，与非西班牙裔白人女性相比，西班牙裔白人的死亡率存在差异。进一步的研究对于发展护理系统以减轻种族差异至关重要。 STEMI 结果。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459415/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459415</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065512>10.1161/CIRCULATIONAHA.123.065512</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459415</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿莎娜·奥修</dc:creator><dc:creator>马塞洛·F·费尔南德斯</dc:creator><dc:creator>Ram Poudel更多</dc:creator><dc:creator>詹姆斯·德莱莫斯</dc:creator><dc:creator>洪浩云</dc:creator><dc:creator>赵娟</dc:creator><dc:creator>沉力</dc:creator><dc:creator>——凯西·托马斯</dc:creator><dc:creator>丹尼尔·菊池</dc:creator><dc:creator>杰西卡·泽格雷-海姆西</dc:creator><dc:creator>纳斯里安·易卜拉欣</dc:creator><dc:creator>尼莱·S·沙阿</dc:creator><dc:creator>洛瑞·霍洛韦尔</dc:creator><dc:creator>杰奎琳·塔米斯-霍兰德</dc:creator><dc:creator>克里斯托弗·B·格兰杰</dc:creator><dc:creator>毛里西奥·科恩</dc:creator><dc:creator>蒂莫西·亨利</dc:creator><dc:creator>艾丽丝·雅各布斯</dc:creator><dc:creator>詹姆斯·G·乔利斯</dc:creator><dc:creator>克莱德·W·扬西</dc:creator><dc:creator>Abhinav Goyal更多</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>2015 年至 2021 年 ST 段抬高型心肌梗死过程指标和死亡率的种族差异：对美国心脏协会 178 062 名遵循冠状动脉疾病登记指南的患者进行的分析</dc:title><dc:identifier>下午：37459415</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065512</dc:identifier></item><item><title>解决心血管差异的复杂自适应系统仿真建模：复杂问题的复杂科学</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459414/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):201-203. doi: 10.1161/CIRCULATIONAHA.122.061728. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459414/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459414</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.061728>10.1161/CIRCULATIONAHA.122.061728</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459414</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>卡迈勒·H·亨德森</dc:creator><dc:creator>罗斯·哈蒙德</dc:creator><dc:creator>杰克·B·霍默</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>解决心血管差异的复杂自适应系统仿真建模：复杂问题的复杂科学</dc:title><dc:identifier>下午：37459414</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.061728</dc:identifier></item><item><title>使用一级预防除颤器的黑人患者和白人患者的心律失常和生存结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459413/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>结论：在采用 ICD 进行一级预防的 NICM 患者中，与白人患者相比，黑人患者接受 VTA、ATA 和 ICD 治疗的风险和负担较高，且生存率较低。与白人患者的情况相似。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):241-252. doi: 10.1161/CIRCULATIONAHA.123.065367. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：美国黑人患非缺血性心肌病 (NICM) 的风险高于美国白人。我们的目的是评估植入式心律转复除颤器 (ICD) 患者发生快速心律失常风险的差异。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：研究人群包括参加初级预防 ICD 试验的 3895 名美国 ICD 接受者。结果指标包括室性快速心律失常 (VTA)、房性快速心律失常 (ATA)、ICD 治疗、VTA 负担（使用 Andersen-Gill 复发事件分析）、死亡以及 ICD 的预测获益。所有事件均采用盲法判定。对自我报告的患有心肌病（缺血性和 NICM）的黑人患者与白人患者的结果进行了比较。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：黑人患者更有可能是女性（35% 对比 22%）且更年轻（57±12 岁对比 62±12 岁），合并症的发生率更高。在 NICM 中，黑人患者首次 VTA 发生率更高，快速VTA、ATA 以及适当和不适当的 ICD 治疗（VTA ≥170 bpm，32% 对 20%；VTA ≥200 bpm，22% 对 14%；ATA，25% 对 12%；适当治疗，30% 对 20%；不适当的治疗，分别为 25% 与 11%；所有<i>P</i> &lt;0.001）。多变量分析显示，患有 NICM 的黑人患者发生所有类型心律失常或 ICD 治疗的风险较高（VTA ≥170 bpm，风险比 [HR] 1.71； VTA ≥200 bpm，HR 1.58；ATA，HR 1.87；适当的治疗，HR 1.62；不适当的治疗，HR 1.86；所有<i>P</i> ≤ 0.01），快速心律失常或治疗的负担较高（VTA，HR 1.84；两者<i>P</i> &lt;0.001） ，以及更高的死亡风险（HR 1.92； <i>P</i> = 0.014）。黑人和白人患者都从 ICD 植入中获得了显着且相似的益处。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在采用 ICD 进行一级预防的 NICM 患者中，与白人患者相比，黑人患者接受 VTA、ATA 和 ICD 治疗的风险和负担较高，且生存率较低。与白人患者的情况相似。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459413/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459413</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065367>10.1161/CIRCULATIONAHA.123.065367</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459413</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿尔瓦·尤尼斯</dc:creator><dc:creator>萨那·阿里</dc:creator><dc:creator>艾琳·希奇</dc:creator><dc:creator>伊多·戈登伯格</dc:creator><dc:creator>斯科特·麦克尼特</dc:creator><dc:creator>布罗尼斯拉娃·波隆斯基</dc:creator><dc:creator>穆罕默德·K·阿克塔斯</dc:creator><dc:creator>瓦伦蒂娜·库蒂法</dc:creator><dc:creator>乌萨马·M·瓦兹尼</dc:creator><dc:creator>沃伊切赫·扎雷巴</dc:creator><dc:creator>伊兰·戈登伯格</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>使用一级预防除颤器的黑人患者和白人患者的心律失常和生存结果</dc:title><dc:identifier>下午：37459413</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065367</dc:identifier></item><item><title>心血管临床试验中培养多样性和实现公平性的策略</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459412/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):204-206. doi: 10.1161/CIRCULATIONAHA.123.065476. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459412/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459412</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065476>10.1161/CIRCULATIONAHA.123.065476</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459412</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>黛布拉·迪克森</dc:creator><dc:creator>康苏埃洛·H·威尔金斯</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>心血管临床试验中培养多样性和实现公平性的策略</dc:title><dc:identifier>下午：37459412</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065476</dc:identifier></item><item><title>促进美国心血管健康公平：既然我们知道了，下一步该往哪里走？</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459411/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):197-198. doi: 10.1161/CIRCULATIONAHA.123.065971. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459411/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459411</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065971>10.1161/CIRCULATIONAHA.123.065971</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459411</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Rishi K Wadhera更多</dc:creator><dc:creator>卡罗尔·E·沃森</dc:creator><dc:creator>梅赛德斯·R·卡内松</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>促进美国心血管健康公平：既然我们知道了，下一步该往哪里走？</dc:title><dc:identifier>下午：37459411</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065971</dc:identifier></item><item><title>美国心脏协会计划旨在提高西班牙裔或拉丁裔临床医生在心脏病学领域的代表性</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459410/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):278-279. doi: 10.1161/CIRCULATIONAHA.123.064251. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459410/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459410</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064251>10.1161/CIRCULATIONAHA.123.064251</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459410</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>布里奇特·M·库恩</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>美国心脏协会计划旨在提高西班牙裔或拉丁裔临床医生在心脏病学领域的代表性</dc:title><dc:identifier>下午：37459410</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064251</dc:identifier></item><item><title>医疗保险受益人的历史红线、社会经济困境和心力衰竭风险</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459409/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>结论：历史红线与黑人患者心力衰竭风险增加相关。当代邮政编码级别的健康社会决定因素改变了红线与心力衰竭风险之间的关系，在社会经济最弱势的社区中观察到红线与心力衰竭之间的关系最强。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):210-219. doi: 10.1161/CIRCULATIONAHA.123.064351. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：历史红线政策（结构性种族主义的标志）与当代白人和黑人心力衰竭（HF）风险之间的关联尚未明确。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们旨在评估白人和黑人医疗保险受益人中红线与心力衰竭风险的关联。邮政编码级别的红线是根据每个邮政编码内使用映射不平等项目的历史红线区域的比例来确定的。邮政编码红线比例使用针对潜在混杂因素进行调整的广义线性混合模型（包括邮政编码级社会剥夺指数的衡量标准），对白人和黑人医疗保险受益人（四分位数 4 与四分位数 1-3）和心力衰竭风险分别进行评估。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：共纳入 2 388 955 名医疗保险受益人（黑人 n=801 452；白人 n=1 587 503；平均年龄 71 岁；男性 44.6%）。黑人受益人中，居住在红线比例较高的邮政编码地区调整年龄、性别和合并症后，（四分位数 4 与四分位数 1-3）与心力衰竭风险增加相关（风险比，1.08 [95% CI，1.04-1.12]； <i>P</i> &lt;0.001）。进一步调整面积-社会剥夺指数（风险比，1.04 [95% CI，1.002-1.08]； <i>P</i> = 0.04）。在红线比例和社会剥夺指数之间观察到显着的交互作用（ <i>P</i><sub>交互</sub>&lt;0.01），因此较高的红线比例显着相关仅在社会经济困难地区（高于社会剥夺指数中位数）存在心力衰竭风险。在白人受益人中，调整年龄、性别和合并症后，红线与心力衰竭风险较低相关（风险比，0.94 [ 95% CI，0.89] -0.99]； <i>P</i> = 0.02）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：历史红线与黑人患者心力衰竭风险增加相关。当代邮政编码级别的健康社会决定因素改变了红线与心力衰竭风险之间的关系，在社会经济最弱势的社区中观察到红线与心力衰竭之间的关系最强。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459409/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459409</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064351>10.1161/CIRCULATIONAHA.123.064351</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459409</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿姆加德·门蒂亚斯更多</dc:creator><dc:creator>Mahasin S Mujahid更多</dc:creator><dc:creator>——安德鲁·苏马索诺</dc:creator><dc:creator>——罗伯特·K·纳尔逊</dc:creator><dc:creator>贾斯汀·马德伦</dc:creator><dc:creator>蒂芙尼·M·鲍威尔-威利</dc:creator><dc:creator>乌蒂贝·R·埃辛</dc:creator><dc:creator>尼尔·凯什瓦尼</dc:creator><dc:creator>萨凯特·吉罗特拉</dc:creator><dc:creator>阿兰娜·莫里斯</dc:creator><dc:creator>马里奥·西姆斯</dc:creator><dc:creator>奎因·卡珀斯</dc:creator><dc:creator>克莱德·扬西</dc:creator><dc:creator>米林德·德赛</dc:creator><dc:creator>维努·梅农</dc:creator><dc:creator>施雷亚·拉奥</dc:creator><dc:creator>安巴里什·潘迪</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>医疗保险受益人的历史红线、社会经济困境和心力衰竭风险</dc:title><dc:identifier>下午：37459409</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064351</dc:identifier></item><item><title>首次心肌梗死后复发性动脉粥样硬化性心血管疾病事件的社会经济差异和中介因素</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459408/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>结论：不参与心脏康复、心脏代谢风险状况和持续吸烟介导 MI 后收入依赖的预后。在缺乏随机试验的情况下，这种因果推理方法可能会指导改善健康公平的决策。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):256-267. doi: 10.1161/CIRCULATIONAHA.123.064440. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：低社会经济地位与心肌梗死 (MI) 后较差的二级预防使用和预后相关。改善健康公平的行动需要确定风险中介因素。因此，我们评估了社会经济地位与首次复发性动脉粥样硬化性心血管疾病事件之间关联的中介因素MI 后 (rASCVD)。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项针对瑞典全民健康覆盖年龄 18 至 76 岁的首例心肌梗死 1 年幸存者的队列研究中，来自 SWEDEHEART（瑞典心脏病循证护理增强和发展网络系统）的个人数据根据推荐疗法）和链接的国家登记处收集了 2006 年至 2020 年期间的数据。暴露程度是按可支配收入五分位（主要代表）、教育水平和婚姻状况划分的社会经济状况。主要结局是 rASCVD，次要结局是心血管疾病和全因疾病我们最初在序贯多变量模型中评估了风险比的增量衰减，其中 95% CI 添加了潜在介质组（即既往危险因素、急性表现和梗死严重程度、初始治疗和二级预防）。使用因果中介分析计算出因不参与心脏康复、次优他汀类药物管理、心脏代谢风险状况、持续吸烟和心肌梗死后血压高于目标而介导的因素。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在 68 775 名参与者（73.8% 男性）中，平均 5.7 年的随访期间发生了 7064 例 rASCVD。根据年龄、性别和历年调整后的收入与 rASCVD 相关（风险比为 1.63 [95% CI]通过调整先前的风险因素以及为最终模型添加二级预防变量（最低收入五分之一与最高收入五分之一的风险比为 1.38 [95% CI，1.26-1.51]），风险得到最大程度的减弱。最低收入五分之一与最高收入五分之一。在收入最低的五分之一中，由于不参与心脏康复、心脏代谢风险状况、持续吸烟和血压控制不良而导致的 15 年 rASCVD 风险过高的比例分别为 3.3% (95% CI 2.1-4.8)、3.9% (95分别为 % CI，2.9-5.5)、15.2% (95% CI 0.6-1.5) 和 1.0% (95% CI 0.6-1.5)。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：不参与心脏康复、心脏代谢风险状况和持续吸烟介导 MI 后收入依赖的预后。在缺乏随机试验的情况下，这种因果推理方法可能会指导改善健康公平的决策。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459408/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459408</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064440>10.1161/CIRCULATIONAHA.123.064440</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459408</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>乔尔·欧姆</dc:creator><dc:creator>拉尔夫·库贾-哈尔科拉</dc:creator><dc:creator>安娜·沃恩奎斯特</dc:creator><dc:creator>亨利克·哈贝尔</dc:creator><dc:creator>佩尔·H·斯科格伦德</dc:creator><dc:creator>约翰·桑德斯特罗姆</dc:creator><dc:creator>克里斯蒂娜·汉布雷厄斯</dc:creator><dc:creator>托马斯·詹伯格</dc:creator><dc:creator>佩尔·斯文森</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>首次心肌梗死后复发性动脉粥样硬化性心血管疾病事件的社会经济差异和中介因素</dc:title><dc:identifier>下午：37459408</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064440</dc:identifier></item><item><title>产前诊断左心发育不良综合征的母亲社会人口统计学与新生儿医院死亡率之间的关联</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459407/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):283-285. doi: 10.1161/CIRCULATIONAHA.123.064476. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459407/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459407</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064476>10.1161/CIRCULATIONAHA.123.064476</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459407</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>凯拉·N·洛佩兹</dc:creator><dc:creator>谢恩·莫里斯</dc:creator><dc:creator>安妮塔·克里希南</dc:creator><dc:creator>玛尼·B·雅各布斯</dc:creator><dc:creator>阿尔蒂·H·巴特</dc:creator><dc:creator>安贾利切利亚</dc:creator><dc:creator>乔安妮·赵</dc:creator><dc:creator>贝蒂娜·F·库内奥</dc:creator><dc:creator>——格蕾丝·弗莱雷</dc:creator><dc:creator>丽莎·K·霍恩伯格</dc:creator><dc:creator>丽莎·豪利</dc:creator><dc:creator>纳齐亚·侯赛因</dc:creator><dc:creator>凯瑟琳·伊肯巴</dc:creator><dc:creator>安·卡瓦诺-麦克休</dc:creator><dc:creator>谢尔比·库蒂</dc:creator><dc:creator>卡罗琳·李</dc:creator><dc:creator>安吉拉·麦克布赖恩</dc:creator><dc:creator>埃里克·米歇尔菲尔德</dc:creator><dc:creator>内兰吉·M·平托</dc:creator><dc:creator>雷切尔·施瓦茨</dc:creator><dc:creator>凯南·WD·斯特恩</dc:creator><dc:creator>卡罗琳·泰勒</dc:creator><dc:creator>瓦莎·塔库尔</dc:creator><dc:creator>韦恩·图雷茨基</dc:creator><dc:creator>卡罗尔·维特利布-韦伯</dc:creator><dc:creator>克里斯·沃尔杜</dc:creator><dc:creator>玛丽·T·多诺弗里奥</dc:creator><dc:creator>Shabnam Peyvandi更多</dc:creator><dc:creator>胎心学会研究合作</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>产前诊断左心发育不良综合征的母亲社会人口统计学与新生儿医院死亡率之间的关联</dc:title><dc:identifier>下午：37459407</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064476</dc:identifier></item><item><title>现在就采取行动：心脏移植后的种族差异</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459406/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):207-209. doi: 10.1161/CIRCULATIONAHA.123.064499. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459406/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459406</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064499>10.1161/CIRCULATIONAHA.123.064499</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459406</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Kiran K Khush更多</dc:creator><dc:creator>汉娜·瓦兰汀</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>现在就采取行动：心脏移植后的种族差异</dc:title><dc:identifier>下午：37459406</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064499</dc:identifier></item><item><title>慢性肾病患者的历史街区红线和心血管风险</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459405/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):280-282.doi: 10.1161/CIRCULATIONAHA.123.064215. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459405/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37459405</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064215>10.1161/CIRCULATIONAHA.123.064215</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459405</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>萨德尔·金迪</dc:creator><dc:creator>伊萨姆·莫泰莱克</dc:creator><dc:creator>凯瑟琳·克雷苏拉斯</dc:creator><dc:creator>杰克逊·T·赖特</dc:creator><dc:creator>米雷拉·多布雷</dc:creator><dc:creator>马布·拉赫曼</dc:creator><dc:creator>桑杰·拉贾戈帕兰 (Sanjay Rajagopalan)</dc:creator><dc:date> 2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>慢性肾病患者的历史街区红线和心血管风险</dc:title><dc:identifier>下午：37459405</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064215</dc:identifier></item><item><title>电子烟和电子烟产品对心肺的影响：美国心脏协会的科学声明</title><link/>https://pubmed.ncbi.nlm.nih.gov/37458106/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>在过去的十年中，电子烟和电子烟的使用呈指数级增长，特别是在青少年中。吸烟是心血管疾病和肺部疾病的危险因素。电子烟和电子烟产品经常被吹捧为更安全的替代品以及潜在的戒烟产品。美国爆发了与电子烟或电子烟产品使用相关的肺损伤…… </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 17 日。doi：10.1161/CIR.0000000000001160。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">在过去的十年中，电子烟和电子烟的使用呈指数级增长，特别是在青少年中。吸烟是心血管疾病和肺部疾病的危险因素。电子烟和电子烟产品经常被吹捧为更安全的替代品2019 年，美国爆发了与电子烟或电子烟产品使用相关的肺损伤，导致超过 2800 人住院，凸显了其中的风险。因此，无需进行药品或医疗器械所需的上市前动物和人类安全研究。2019 年美国高中生的使用率高达 27.5%，因此评估短期和长期的效果至关重要。这些产品对健康的长期影响，以及减少青少年使用的干预和公共卫生努力的发展。本科学声明的目标是（1）描述和讨论青少年和成人中电子烟和电子烟产品的使用模式； (2) 识别电子烟气溶胶中有害和潜在有害的成分；(3) 严格评估有关电子烟和电子烟产品使用的急性和慢性心血管和肺部风险的分子、动物和临床证据；(4)描述电子烟和电子烟产品作为潜在戒烟产品的当前证据；5) 总结当前电子烟和电子烟产品的公共卫生和监管工作。临床证据表明电子尼古丁输送系统会产生各种急性生理效应，特别是那些含有尼古丁的产品。随着这些产品的使用不断增长，迫切需要进行额外的临床和动物暴露模型研究。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37458106/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37458106</a> | DOI： <a href=https://doi.org/10.1161/CIR.0000000000001160>10.1161/CIR.0000000000001160</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37458106</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>杰森·J·罗斯</dc:creator><dc:creator>苏奇特拉·克里希南·沙林</dc:creator><dc:creator>韦尔纳·J·埃克西尔</dc:creator><dc:creator>——内奥米·汉堡</dc:creator><dc:creator>——杰西卡·L·费特曼</dc:creator><dc:creator>一之濑文人</dc:creator><dc:creator>米格尔·佩雷斯-平松更多</dc:creator><dc:creator>玛丽·雷兹克·汉娜</dc:creator><dc:creator>埃里克·威廉姆森</dc:creator><dc:creator>美国心脏协会心肺、重症监护、围手术期和复苏委员会；流行病学和预防委员会；心血管放射学和干预委员会；生活方式和心脏代谢健康委员会；血管生物学</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>电子烟和电子烟产品对心肺的影响：美国心脏协会的科学声明</dc:title><dc:identifier>下午：37458106</dc:identifier><dc:identifier>号码：10.1161/CIR.0000000000001160</dc:identifier></item><item><title>国际医学期刊编辑委员会的新建议：人工智能的使用</title><link/>https://pubmed.ncbi.nlm.nih.gov/37453047/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad448.doi: 10.1093/eurheartj/ehad448. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37453047/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37453047</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad448>10.1093/eurheartj/ehad448</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37453047</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator>费尔南多·阿方索</dc:creator><dc:creator>菲利波·克雷亚</dc:creator><dc:date>2023-07-15</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>国际医学期刊编辑委员会的新建议：人工智能的使用</dc:title><dc:identifier>下午：37453047</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad448</dc:identifier></item><item><title>人工智能通过经胸超声心动图检测左心耳血栓和临床特征：经食管超声心动图左心耳血栓 (LATTEE) 登记处</title><link/>https://pubmed.ncbi.nlm.nih.gov/37453044/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718063150&amp;v=2.17.9.post6+86293ac<description>结论：LAT-AI 可以准确预测 LAT。尽管存在慢性 OAC，但基于 LAT-AI 的方案可用于指导执行 TOE 的决定。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad431.doi: 10.1093/eurheartj/ehad431. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：经食管超声心动图 (TOE) 通常在导管消融或心脏复律之前进行，以排除长期口服抗凝 (OAC) 患者左心耳血栓 (LAT) 的存在，尽管存在相关不适。智能 (AI)] 的开发是为了根据临床和经胸超声心动图 (TTE) 特征预测 LAT 的存在。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: Data from a 13-site prospective registry of patients who underwent TOE before cardioversion or catheter ablation were used. LAT-AI was trained to predict LAT using data from 12 sites (n = 2827) and tested externally in patients on chronic OAC from two sites (n = 1284). Areas under the receiver operating characteristic curve (AUC) of LAT-AI were compared with that of left ventricular ejection fraction (LVEF) and CHA2DS2-VASc score. A decision threshold allowing for a 99% negative predictive value was defined in the development cohort. A protocol where TOE in patients on chronic OAC is performed depending on the LAT-AI score was validated in the external cohort. In the external testing cohort, LAT was found in 5.5% of patients. LAT-AI achieved an AUC of 0.85 [95% confidence interval (CI): 0.82-0.89], outperforming LVEF (0.81, 95% CI 0.76-0.86, P &lt; .0001) and CHA2DS2-VASc score (0.69, 95% CI: 0.63-0.7, P &lt; .0001) in the entire external cohort. Based on the proposed protocol, 40% of patients on chronic OAC from the external cohort would safely avoid TOE. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: LAT-AI allows accurate prediction of LAT. A LAT-AI-based protocol could be used to guide the decision to perform TOE despite chronic OAC.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37453044/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37453044</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad431>10.1093/eurheartj/ehad431</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37453044</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Konrad Pieszko</dc:creator><dc:creator> Jarosław Hiczkiewicz</dc:creator><dc:creator> Katarzyna Łojewska</dc:creator><dc:creator> Beata Uziębło-Życzkowska</dc:creator><dc:creator> Paweł Krzesiński</dc:creator><dc:creator> Monika Gawałko</dc:creator><dc:creator> Monika Budnik</dc:creator><dc:creator> Katarzyna Starzyk</dc:creator><dc:creator> Beata Wożakowska-Kapłon</dc:creator><dc:creator> Ludmiła Daniłowicz-Szymanowicz</dc:creator><dc:creator> Damian Kaufmann</dc:creator><dc:creator> Maciej Wójcik</dc:creator><dc:creator> Robert Błaszczyk</dc:creator><dc:creator> Katarzyna Mizia-Stec</dc:creator><dc:creator> Maciej Wybraniec</dc:creator><dc:creator> Katarzyna Kosmalska</dc:creator><dc:creator> Marcin Fijałkowski</dc:creator><dc:creator> Anna Szymańska</dc:creator><dc:creator> Mirosław Dłużniewski</dc:creator><dc:creator> Michał Kucio</dc:creator><dc:creator> Maciej Haberka</dc:creator><dc:creator> Karolina Kupczyńska</dc:creator><dc:creator> Błażej Michalski</dc:creator><dc:creator> Anna Tomaszuk-Kazberuk</dc:creator><dc:creator> Katarzyna Wilk-Śledziewska</dc:creator><dc:creator> Renata Wachnicka-Truty</dc:creator><dc:creator> Marek Koziński</dc:creator><dc:creator> Jacek Kwieciński</dc:creator><dc:creator> Rafał Wolny</dc:creator><dc:creator> Ewa Kowalik</dc:creator><dc:creator> Iga Kolasa</dc:creator><dc:creator> Agnieszka Jurek</dc:creator><dc:creator> Jan Budzianowski</dc:creator><dc:creator> Paweł Burchardt</dc:creator><dc:creator> Agnieszka Kapłon-Cieślicka</dc:creator><dc:creator> Piotr J Slomka</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry</dc:title><dc:identifier> pmid:37453044</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad431</dc:identifier></item><item><title> Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis</title><link/> https://pubmed.ncbi.nlm.nih.gov/37452732/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718063150&amp;v=2.17.9.post6+86293ac<description> CONCLUSION: The present model provides an absolute, individualized probability of PE presence in a broad population of patients with suspected PE, with very good discrimination and calibration. Its clinical utility needs to be evaluated in a prospective management or impact study. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad417. doi: 10.1093/eurheartj/ehad417. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Risk stratification is used for decisions regarding need for imaging in patients with clinically suspected acute pulmonary embolism (PE). The aim was to develop a clinical prediction model that provides an individualized, accurate probability estimate for the presence of acute PE in patients with suspected disease based on readily available clinical items and D-dimer concentrations. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: An individual patient data meta-analysis was performed based on sixteen cross-sectional or prospective studies with data from 28 305 adult patients with clinically suspected PE from various clinical settings, including primary care, emergency care, hospitalized and nursing home patients. A multilevel logistic regression model was built and validated including ten a priori defined objective candidate predictors to predict objectively confirmed PE at baseline or venous thromboembolism (VTE) during follow-up of 30 to 90 days. Multiple imputation was used for missing data. Backward elimination was performed with a P-value &lt;0.10. Discrimination (c-statistic with 95% confidence intervals [CI] and prediction intervals [PI]) and calibration (outcome:expected [O:E] ratio and calibration plot) were evaluated based on internal-external cross-validation. The accuracy of the model was subsequently compared with algorithms based on the Wells score and D-dimer testing. The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep vein thrombosis, inpatient status, D-dimer (in µg/L), and an interaction term between age and D-dimer. The pooled c-statistic was 0.87 (95% CI, 0.85-0.89; 95% PI, 0.77-0.93) and overall calibration was very good (pooled O:E ratio, 0.99; 95% CI, 0.87-1.14; 95% PI, 0.55-1.79). The model slightly overestimated VTE probability in the lower range of estimated probabilities. Discrimination of the current model in the validation data sets was better than that of the Wells score combined with a D-dimer threshold based on age (c-statistic 0.73; 95% CI, 0.70-0.75) or structured clinical pretest probability (c-statistic 0.79; 95% CI, 0.76-0.81). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: The present model provides an absolute, individualized probability of PE presence in a broad population of patients with suspected PE, with very good discrimination and calibration. Its clinical utility needs to be evaluated in a prospective management or impact study. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> REGISTRATION: PROSPERO ID 89366.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37452732/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37452732</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad417>10.1093/eurheartj/ehad417</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37452732</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Nick van Es</dc:creator><dc:creator> Toshihiko Takada</dc:creator><dc:creator> Noémie Kraaijpoel</dc:creator><dc:creator> Frederikus A Klok</dc:creator><dc:creator> Milou AM Stals</dc:creator><dc:creator> Harry R Büller</dc:creator><dc:creator> D Mark Courtney</dc:creator><dc:creator> Yonathan Freund</dc:creator><dc:creator> Javier Galipienzo</dc:creator><dc:creator> Grégoire Le Gal</dc:creator><dc:creator> Waleed Ghanima</dc:creator><dc:creator> Menno V Huisman</dc:creator><dc:creator> Jeffrey A Kline</dc:creator><dc:creator> Karel GM Moons</dc:creator><dc:creator> Sameer Parpia</dc:creator><dc:creator> Arnaud Perrier</dc:creator><dc:creator> Marc Righini</dc:creator><dc:creator> Helia Robert-Ebadi</dc:creator><dc:creator> Pierre-Marie Roy</dc:creator><dc:creator> Phil S Wells</dc:creator><dc:creator> Kerstin de Wit</dc:creator><dc:creator> Maarten van Smeden</dc:creator><dc:creator> Geert-Jan Geersing</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis</dc:title><dc:identifier> pmid:37452732</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad417</dc:identifier></item><item><title> Heart failure and socioeconomic status: global differences and inequalities</title><link/> https://pubmed.ncbi.nlm.nih.gov/37452730/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718063150&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad410. doi: 10.1093/eurheartj/ehad410. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37452730/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37452730</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad410>10.1093/eurheartj/ehad410</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37452730</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Rocco Vergallo</dc:creator><dc:creator> Carlo Patrono</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> Heart failure and socioeconomic status: global differences and inequalities</dc:title><dc:identifier> pmid:37452730</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad410</dc:identifier></item><item><title> Heart transplantation: advances in expanding the donor pool and xenotransplantation</title><link/> https://pubmed.ncbi.nlm.nih.gov/37452122/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718063150&amp;v=2.17.9.post6+86293ac<description> Approximately 65 million adults globally have heart failure, and the prevalence is expected to increase substantially with ageing populations. Despite advances in pharmacological and device therapy of heart failure, long-term morbidity and mortality remain high. Many patients progress to advanced heart failure and develop persistently severe symptoms. Heart transplantation remains the gold-standard therapy to improve the quality of life, functional status and survival of these patients. However,... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol. 2023 Jul 14. doi: 10.1038/s41569-023-00902-1. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Approximately 65 million adults globally have heart failure, and the prevalence is expected to increase substantially with ageing populations. Despite advances in pharmacological and device therapy of heart failure, long-term morbidity and mortality remain high. Many patients progress to advanced heart failure and develop persistently severe symptoms. Heart transplantation remains the gold-standard therapy to improve the quality of life, functional status and survival of these patients. However, there is a large imbalance between the supply of organs and the demand for heart transplants. Therefore, expanding the donor pool is essential to reduce mortality while on the waiting list and improve clinical outcomes in this patient population. A shift has occurred to consider the use of organs from donors with hepatitis C virus, HIV or SARS-CoV-2 infection. Other advances in this field have also expanded the donor pool, including opt-out donation policies, organ donation after circulatory death and xenotransplantation. We provide a comprehensive overview of these various novel strategies, provide objective data on their safety and efficacy, and discuss some of the unresolved issues and controversies of each approach.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37452122/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37452122</a> | DOI: <a href=https://doi.org/10.1038/s41569-023-00902-1>10.1038/s41569-023-00902-1</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37452122</guid><pubDate> Fri, 14 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Stephanie Jou</dc:creator><dc:creator> Sean R Mendez</dc:creator><dc:creator> Jason Feinman</dc:creator><dc:creator> Lindsey R Mitrani</dc:creator><dc:creator> Valentin Fuster</dc:creator><dc:creator> Massimo Mangiola</dc:creator><dc:creator> Nader Moazami</dc:creator><dc:creator> Claudia Gidea</dc:creator><dc:date> 2023-07-14</dc:date><dc:source> Nature reviews. Cardiology</dc:source><dc:title> Heart transplantation: advances in expanding the donor pool and xenotransplantation</dc:title><dc:identifier> pmid:37452122</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00902-1</dc:identifier></item><item><title> Vegetarian and vegan diets: benefits and drawbacks</title><link/> https://pubmed.ncbi.nlm.nih.gov/37450568/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718063150&amp;v=2.17.9.post6+86293ac<description> Plant-based diets have become increasingly popular thanks to their purported health benefits and more recently for their positive environmental impact. Prospective studies suggest that consuming vegetarian diets is associated with a reduced risk of developing cardiovascular disease (CVD), diabetes, hypertension, dementia, and cancer. Data from randomized clinical trials have confirmed a protective effect of vegetarian diets for the prevention of diabetes and reductions in weight, blood pressure,... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 14:ehad436. doi: 10.1093/eurheartj/ehad436. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Plant-based diets have become increasingly popular thanks to their purported health benefits and more recently for their positive environmental impact. Prospective studies suggest that consuming vegetarian diets is associated with a reduced risk of developing cardiovascular disease (CVD), diabetes, hypertension, dementia, and cancer. Data from randomized clinical trials have confirmed a protective effect of vegetarian diets for the prevention of diabetes and reductions in weight, blood pressure, glycosylated haemoglobin and low-density lipoprotein cholesterol, but to date, no data are available for cardiovascular event rates and cognitive impairment, and there are very limited data for cancer. Moreover, not all plant-based foods are equally healthy. Unhealthy vegetarian diets poor in specific nutrients (vitamin B12, iron, zinc, and calcium) and/or rich in highly processed and refined foods increase morbidity and mortality. Further mechanistic studies are desirable to understand whether the advantages of healthy, minimally processed vegetarian diets represent an all-or-nothing phenomenon and whether consuming primarily plant-based diets containing small quantities of animal products (eg pesco-vegetarian or Mediterranean diets) has beneficial, detrimental, or neutral effects on cardiometabolic health outcomes. Further, mechanistic studies are warranted to enhance our understanding about healthy plant-based food patterns and the biological mechanisms linking dietary factors, CVD, and other metabolic diseases.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37450568/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37450568</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad436>10.1093/eurheartj/ehad436</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37450568</guid><pubDate> Fri, 14 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Tian Wang</dc:creator><dc:creator> Andrius Masedunskas</dc:creator><dc:creator> Walter C Willett</dc:creator><dc:creator> Luigi Fontana</dc:creator><dc:date> 2023-07-14</dc:date><dc:source> European heart journal</dc:source><dc:title> Vegetarian and vegan diets: benefits and drawbacks</dc:title><dc:identifier> pmid:37450568</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad436</dc:identifier></item><item><title> The European Heart Journal&#39;s top contributing institutions: the Royal Brompton and Harefield hospitals, UK</title><link/> https://pubmed.ncbi.nlm.nih.gov/37450561/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718063150&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 14:ehad442. doi: 10.1093/eurheartj/ehad442. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37450561/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718063150&v=2.17.9.post6+86293ac">37450561</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad442>10.1093/eurheartj/ehad442</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37450561</guid><pubDate> Fri, 14 Jul 2023 06:00:00 -0400</pubDate><dc:date> 2023-07-14</dc:date><dc:source> European heart journal</dc:source><dc:title> The European Heart Journal&#39;s top contributing institutions: the Royal Brompton and Harefield hospitals, UK</dc:title><dc:identifier> pmid:37450561</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad442</dc:identifier></item></channel></rss>